Product Code: A00532
Title:
Digital PCR Market by Treatment Type (Droplet Digital PCR and BEAMing Digital PCR), Product Type (Digital PCR Systems, Consumables & Reagents, and Software & Services), Application (Research, Clinical Diagnostics, and Forensic & Others), and End User (Pharmaceuticals & Biotechnology Industries, Clinical Diagnostic Laboratories, and Universities & Other Organizations): Opportunity Analysis and Industry Forecast, 2020-2027.
The global digital polymerase chain reaction market generated $398 million in 2019, and is projected to reach $1,052 million by 2027, growing at a CAGR of 12.3% from 2020 to 2027.
Digital polymerase chain reaction (dPCR) is a new approach for detection and quantification of nucleic acids that provides a sensitive and reproducible way to measure the amount of DNA or RNA present in a sample. dPCR exhibits high potential in the research (basic research and applied research), clinical diagnostics, forensics, and others similar arenas. dPCR systems are useful for copy number variation, rare sequence detection, mutation detection, miRNA analysis, gene expression analysis, and next-generation sequencing sample quantification.
The global digital polymerase chain reaction market is expected to register substantial growth in the near future, owing to rise in prevalence of infectious diseases and increase in awareness & acceptance of personalized medicines. In addition, advancements in the technique is expected to boost the market growth during the forecast period. However, high cost of dPCR devices and reimbursement issues are the factors anticipated to hamper the market growth during the forecast period. Conversely, increase in funding for R&D activities is expected to offer remunerative opportunities for market players.
The global digital polymerase chain reaction market is segmented into technology, type, application, end user, and region. By technology, the market is categorized into droplet digital PCR (ddPCR) and BEAMing digital PCR.
Depending on type, it is fragmented into digital PCR systems, consumables & reagents, and software & services. On the basis of application, it is segregated into research, clinical diagnostics, and forensic & others. As per end user, it is differentiated into pharmaceuticals & biotechnology industries, clinical diagnostic laboratories, and universities & other organizations. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players operating in the global digital polymerase chain reaction market include Bio-Rad Laboratories, Inc., 4basebio AG, Fluidigm Corporation, JN Medsys, Merck KGaA, Qiagen N.V., Stilla Technologies, Sysmex Corporation, Combinati, Inc., and Thermo Fisher Scientific, Inc. Product launch and acquisition was the most common strategies adopted among key players to expand their product offerings and strengthen their foothold in the global market.
KEY BENEFITS FOR STAKEHOLDERS
This report highlights the market dynamics to understand the global digital polymerase chain reaction market and capitalize on the prevailing opportunities.
Quantitative analysis of the current trends and future estimations assist stakeholders to design business strategies accordingly.
Porter's five forces analysis examines the competitive market structure and provides a deeper understanding of the influencing factors for entry and expansion.
Pin-point analysis of geographical segments offers identification of most profitable segments to capitalize on.
Key Market Segments
By Treatment Type
Droplet Digital PCR
BEAMing Digital PCR
By Product Type
Digital PCR Systems
Consumables & Reagents
Software & Services
By Application
Research
Clinical Diagnostics
Forensic & Others
By End User
Pharmaceuticals & Biotechnology Industries
Clinical Diagnostic Laboratories
Universities & Other Organizations
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Taiwan
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
List of key players profiled in the report
4basebio AG
Bio-Rad Laboratories, Inc.
Combinati, Inc.
Fluidigm Corporation
JN Medsys
Merck KGaA
Qiagen N.V.
Stilla Technologies
Sysmex Corporation
Thermo Fisher Scientific, Inc
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
Promega Corporation
Takara Bio Inc.
Avance Biosciences Inc.
TABLE OF CONTENTS
CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key benefits for stakeholders
- 1.3.Key market segments
- 1.4.Research methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools & models
CHAPTER 2:EXECUTIVE SUMMARY
CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter's five forces analysis
- 3.4.Top player positioning, 2019
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.1.1.Rise in prevalence of infectious diseases and cancer
- 3.5.1.2.Increase in awareness and acceptance of personalized medicines
- 3.5.1.3.Technological advancements
- 3.5.2.Restraints
- 3.5.2.1.High cost of dPCR devices
- 3.5.2.2.Reimbursement issues
- 3.5.3.Opportunity
- 3.5.3.1.Increase in funding for R&D activities
- 3.6.Impact analysis of COVID-19 on the digital PCR market
CHAPTER 4:DIGITAL POLYMERASE CHAIN REACTION MARKET, BY TECHNOLOGY
- 4.1.Overview
- 4.1.1.Market size and forecast
- 4.2.Droplet digital PCR
- 4.2.1.Key market trends, growth factors, and opportunities
- 4.2.2.Market size and forecast
- 4.2.3.Market analysis, by country
- 4.3.BEAMing dPCR
- 4.3.1.Key market trends, growth factors, and opportunities
- 4.3.2.Market size and forecast
- 4.3.3.Market analysis, by country
CHAPTER 5:DIGITAL POLYMERASE CHAIN REACTION MARKET, BY PRODUCT TYPE
- 5.1.Overview
- 5.1.1.Market size and forecast
- 5.2.Consumables & reagents
- 5.2.1.Market size and forecast
- 5.2.2.Market analysis, by country
- 5.3.Digital PCR systems
- 5.3.1.Market size and forecast
- 5.3.2.Market analysis, by country
- 5.4.Software & services
- 5.4.1.Market size and forecast
- 5.4.2.Market analysis, by country
CHAPTER 6:DIGITAL POLYMERASE CHAIN REACTION MARKET, BY APPLICATION
- 6.1.Overview
- 6.1.1.Market size and forecast
- 6.2.Research
- 6.2.1.Market size and forecast
- 6.2.2.Market analysis, by country
- 6.3.Clinical diagnostics
- 6.3.1.Market size and forecast
- 6.3.2.Market analysis, by country
- 6.4.Forensic & others
- 6.4.1.Market size and forecast
- 6.4.2.Market analysis, by country
CHAPTER 7:DIGITAL POLYMERASE CHAIN REACTION MARKET, BY END USER
- 7.1.Overview
- 7.1.1.Market size and forecast
- 7.2.Clinical diagnostic laboratories
- 7.2.1.Market size and forecast
- 7.2.2.Market analysis, by country
- 7.3.Pharmaceuticals & biotechnology industries
- 7.3.1.Market size and forecast
- 7.3.2.Market analysis, by country
- 7.4.Universities & other organizations
- 7.4.1.Market size and forecast
- 7.4.2.Market analysis, by country
CHAPTER 8:DIGITAL POLYMERASE CHAIN REACTION MARKET, BY REGION
- 8.1.OVERVIEW
- 8.1.1.Market size and forecast
- 8.2.North America
- 8.2.1.Key market trends and opportunities
- 8.2.2.North America digital PCR market, by country
- 8.2.2.1.U.S. digital PCR market, by technology
- 8.2.2.2.U.S. digital PCR market, by product type
- 8.2.2.3.U.S. digital PCR market, by application
- 8.2.2.4.U.S. digital PCR market, by end user
- 8.2.2.5.Canada digital PCR market, by technology
- 8.2.2.6.Canada digital PCR market, by product type
- 8.2.2.7.Canada digital PCR market, by application
- 8.2.2.8.Canada digital PCR market, by end user
- 8.2.2.9.Mexico digital PCR market, by technology
- 8.2.2.10.Mexico digital PCR market, by product type
- 8.2.2.11.Mexico digital PCR market, by application
- 8.2.2.12.Mexico digital PCR market, by end user
- 8.2.3.North America digital PCR market, by technology
- 8.2.4.North America digital PCR market, by product type
- 8.2.5.North America digital PCR market, by application
- 8.2.6.North America digital PCR market, by end user
- 8.3.Europe
- 8.3.1.Key market trends and opportunities
- 8.3.2.Europe digital PCR market, by country
- 8.3.2.1.Germany digital PCR market, by technology
- 8.3.2.2.Germany digital PCR market, by product type
- 8.3.2.3.Germany digital PCR market, by application
- 8.3.2.4.Germany digital PCR market, by end user
- 8.3.2.5.France digital PCR market, by technology
- 8.3.2.6.France digital PCR market, by product type
- 8.3.2.7.France digital PCR market, by application
- 8.3.2.8.France digital PCR market, by end user
- 8.3.2.9.UK digital PCR market, by technology
- 8.3.2.10.UK digital PCR market, by product type
- 8.3.2.11.UK digital PCR market, by application
- 8.3.2.12.UK digital PCR market, by end user
- 8.3.2.13.Italy digital PCR market, by technology
- 8.3.2.14.Italy digital PCR market, by product type
- 8.3.2.15.Italy digital PCR market, by application
- 8.3.2.16.Italy digital PCR market, by end user
- 8.3.2.17.Spain digital PCR market, by technology
- 8.3.2.18.Spain digital PCR market, by product type
- 8.3.2.19.Spain digital PCR market, by application
- 8.3.2.20.Spain digital PCR market, by end user
- 8.3.2.21.Rest of Europe digital PCR market, by technology
- 8.3.2.22.Rest of Europe digital PCR market, by product type
- 8.3.2.23.Rest of Europe digital PCR market, by application
- 8.3.2.24.Rest of Europe digital PCR market, by end user
- 8.3.3.Europe digital PCR market, by technology
- 8.3.4.Europe digital PCR market, by product type
- 8.3.5.Europe digital PCR market, by application
- 8.3.6.Europe digital PCR market, by end user
- 8.4.Asia-Pacific
- 8.4.1.Key market trends and opportunities
- 8.4.2.Asia-Pacific digital PCR market, by country
- 8.4.2.1.Japan digital PCR market, by technology
- 8.4.2.2.Japan digital PCR market, by product type
- 8.4.2.3.Japan digital PCR market, by application
- 8.4.2.4.Japan digital PCR market, by end user
- 8.4.2.5.China digital PCR market, by technology
- 8.4.2.6.China digital PCR market, by product type
- 8.4.2.7.China digital PCR market, by application
- 8.4.2.8.China digital PCR market, by end user
- 8.4.2.9.Australia digital PCR market, by technology
- 8.4.2.10.Australia digital PCR market, by product type
- 8.4.2.11.Australia digital PCR market, by application
- 8.4.2.12.Australia digital PCR market, by end user
- 8.4.2.13.India digital PCR market, by technology
- 8.4.2.14.India digital PCR market, by product type
- 8.4.2.15.India digital PCR market, by application
- 8.4.2.16.India digital PCR market, by end user
- 8.4.2.17.South Korea digital PCR market, by technology
- 8.4.2.18.South Korea digital PCR market, by product type
- 8.4.2.19.South Korea digital PCR market, by application
- 8.4.2.20.South Korea digital PCR market, by end user
- 8.4.2.21.Taiwan digital PCR market, by technology
- 8.4.2.22.Taiwan digital PCR market, by product type
- 8.4.2.23.Taiwan digital PCR market, by application
- 8.4.2.24.Taiwan digital PCR market, by end user
- 8.4.2.25.Rest of Asia-Pacific digital PCR market, by technology
- 8.4.2.26.Rest of Asia-Pacific digital PCR market, by product type
- 8.4.2.27.Rest of Asia-Pacific digital PCR market, by application
- 8.4.2.28.Rest of Asia-Pacific digital PCR market, by end user
- 8.4.3.Asia-Pacific digital PCR market, by technology
- 8.4.4.Asia-Pacific digital PCR market, by product type
- 8.4.5.Asia-Pacific digital PCR market, by application
- 8.4.6.Asia-Pacific digital PCR market, by end user
- 8.5.LAMEA
- 8.5.1.Key market trends and opportunities
- 8.5.2.LAMEA digital PCR market, by country
- 8.5.2.1.Brazil digital PCR market, by technology
- 8.5.2.2.Brazil digital PCR market, by product type
- 8.5.2.3.Brazil digital PCR market, by application
- 8.5.2.4.Brazil digital PCR market, by end user
- 8.5.2.5.Saudi Arabia digital PCR market, by technology
- 8.5.2.6.Saudi Arabia digital PCR market, by product type
- 8.5.2.7.Saudi Arabia digital PCR market, by application
- 8.5.2.8.Saudi Arabia digital PCR market, by end user
- 8.5.2.9.South Africa digital PCR market, by technology
- 8.5.2.10.South Africa digital PCR market, by product type
- 8.5.2.11.South Africa digital PCR market, by application
- 8.5.2.12.South Africa digital PCR market, by end user
- 8.5.2.13.Rest of LAMEA digital PCR market, by technology
- 8.5.2.14.Rest of LAMEA digital PCR market, by product type
- 8.5.2.15.Rest of LAMEA digital PCR market, by application
- 8.5.2.16.Rest of LAMEA digital PCR market, by end user
- 8.5.3.LAMEA digital PCR market, by technology
- 8.5.4.LAMEA digital PCR market, by product type
- 8.5.5.LAMEA digital PCR market, by application
- 8.5.6.LAMEA digital PCR market, by end user
CHAPTER 9:COMPANY PROFILES
- 9.1.BIO-RAD LABORATORIES, INC.
- 9.1.1.Company overview
- 9.1.2.Company snapshot
- 9.1.3.Operating business segments
- 9.1.4.Product portfolio
- 9.1.5.Business performance
- 9.1.6.Key strategic moves and developments
- 9.2.4BASEBIO AG
- 9.2.1.Company overview
- 9.2.2.Company snapshot
- 9.2.3.Operating business segments
- 9.2.4.Product portfolio
- 9.2.5.Business Performance
- 9.3.COMBINATI, INC.
- 9.3.1.Company overview
- 9.3.2.Company snapshot
- 9.3.3.Operating business segments
- 9.3.4.Product portfolio
- 9.3.5.Key strategic moves and developments
- 9.4.FLUIDIGM CORPORATION
- 9.4.1.Company overview
- 9.4.2.Company snapshot
- 9.4.3.Operating business segments
- 9.4.4.Product portfolio
- 9.4.5.Business performance
- 9.5.JN MEDSYS
- 9.5.1.Company overview
- 9.5.2.Company snapshot
- 9.5.3.Product portfolio
- 9.5.4.Key strategic moves and developments
- 9.6.MERCK KGAA
- 9.6.1.Company overview
- 9.6.2.Company snapshot
- 9.6.3.Operating business segments
- 9.6.4.Product portfolio
- 9.6.5.Business performance
- 9.6.6.Key strategic moves and developments
- 9.7.QIAGEN N.V.
- 9.7.1.Company overview
- 9.7.2.Company snapshot
- 9.7.3.Operating business segment
- 9.7.4.Product portfolio
- 9.7.5.Business performance
- 9.7.6.Key strategic moves and developments
- 9.8.SYSMEX CORPORATION
- 9.8.1.Company overview
- 9.8.2.Company snapshot
- 9.8.3.Operating business segments
- 9.8.4.Product portfolio
- 9.8.5.Business performance
- 9.9.STILLA TECHNOLOGIES
- 9.9.1.Company overview
- 9.9.2.Company snapshot
- 9.9.3.Product portfolio
- 9.9.4.Key strategic moves and developments
- 9.10.THERMO FISHER SCIENTIFIC, INC.
- 9.10.1.Company overview
- 9.10.2.Company snapshot
- 9.10.3.Operating business segments
- 9.10.4.Product portfolio
- 9.10.5.Business performance
比較リスト
